{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:15:10Z","timestamp":1792790110701,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R03CA245996"],"award-info":[{"award-number":["R03CA245996"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA262754"],"award-info":[{"award-number":["R01CA262754"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>B-cell receptor (BCR) signaling plays an important role in the pathogenesis of mantle cell lymphoma (MCL), but the detailed mechanisms are not fully understood. In this study, through a genome-wide loss-of-function screen, we identify carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) as an essential factor in a subset of MCL tumors. Our signal transduction studies reveal that CEACAM1 plays a critical role in BCR activation through involvement in two dynamic processes. First, following BCR engagement, CEACAM1 co-localizes to the membrane microdomains (lipid rafts) by anchoring to the F-actin cytoskeleton through the adaptor protein filamin A. Second, CEACAM1 recruits and increases the abundance of SYK in the BCR complex leading to BCR activation. These activities of CEACAM1 require its cytoplasmic tail and the N-terminal ectodomain. Considering that previous studies have extensively characterized CEACAM1 as an ITIM-bearing inhibitory receptor, our findings regarding its activating role are both surprising and context-dependent, which may have implications for BCR-targeting therapies.<\/jats:p>","DOI":"10.1038\/s41467-025-60208-3","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:42:09Z","timestamp":1748457729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9786-4862","authenticated-orcid":false,"given":"Serene","family":"Xavier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3584-7530","authenticated-orcid":false,"given":"Vishal","family":"Khairnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-0399","authenticated-orcid":false,"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0480-5597","authenticated-orcid":false,"given":"Michael S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi P.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Sadras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan V.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6243-6008","authenticated-orcid":false,"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl S.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-5713","authenticated-orcid":false,"given":"Geoffrey P.","family":"Shouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4461-0970","authenticated-orcid":false,"given":"Alexey V.","family":"Danilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Y.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-8469","authenticated-orcid":false,"given":"Samir","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-8613","authenticated-orcid":false,"given":"Markus","family":"M\u00fcschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9501-6990","authenticated-orcid":false,"given":"Vu N.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"60208_CR1","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","volume":"118","author":"A Hadzidimitriou","year":"2011","unstructured":"Hadzidimitriou, A. et al. Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood 118, 3088\u20133095 (2011).","journal-title":"Blood"},{"key":"60208_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s13402-011-0019-7","volume":"34","author":"C Pighi","year":"2011","unstructured":"Pighi, C. et al. Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. Cell. Oncol. 34, 141\u2013153 (2011).","journal-title":"Cell. Oncol."},{"key":"60208_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2141.2005.05883.x","volume":"132","author":"A Rinaldi","year":"2006","unstructured":"Rinaldi, A. et al. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br. J. Haematol. 132, 303\u2013316 (2006).","journal-title":"Br. J. Haematol."},{"key":"60208_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","volume":"369","author":"ML Wang","year":"2013","unstructured":"Wang, M. L. et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. 369, 507\u2013516 (2013).","journal-title":"N. Engl. J. Med."},{"key":"60208_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1200\/JCO.2012.42.7906","volume":"31","author":"RH Advani","year":"2013","unstructured":"Advani, R. H. et al. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies. J. Clin. Oncol. 31, 88\u201394 (2013).","journal-title":"J. Clin. Oncol."},{"key":"60208_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bjh.14241","volume":"175","author":"CW Eskelund","year":"2016","unstructured":"Eskelund, C. W. et al. 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau. Br. J. Haematol. 175, 410\u2013418 (2016).","journal-title":"Br. J. Haematol."},{"key":"60208_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature08638","volume":"463","author":"RE Davis","year":"2010","unstructured":"Davis, R. E. et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463, 88\u201392 (2010).","journal-title":"Nature"},{"key":"60208_CR8","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1126\/science.1153629","volume":"319","author":"G Lenz","year":"2008","unstructured":"Lenz, G. et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676\u20131679 (2008).","journal-title":"Science"},{"key":"60208_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115\u2013119 (2011).","journal-title":"Nature"},{"key":"60208_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","volume":"489","author":"M D\u00fchren-von Minden","year":"2012","unstructured":"D\u00fchren-von Minden, M. et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489, 309\u2013312 (2012).","journal-title":"Nature"},{"key":"60208_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/scbi.1998.0119","volume":"9","author":"S Hammarstrom","year":"1999","unstructured":"Hammarstrom, S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9, 67\u201381 (1999).","journal-title":"Semin. Cancer Biol."},{"key":"60208_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/44.1.8543780","volume":"44","author":"F Prall","year":"1996","unstructured":"Prall, F. et al. CD66a (BGP), an adhesion molecule of the carcinoembryonic antigen family, is expressed in epithelium, endothelium, and myeloid cells in a wide range of normal human tissues. J. Histochem. Cytochem. 44, 35\u201341 (1996).","journal-title":"J. Histochem. Cytochem."},{"key":"60208_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nri1864","volume":"6","author":"SD Gray-Owen","year":"2006","unstructured":"Gray-Owen, S. D. & Blumberg, R. S. CEACAM1: contact-dependent control of immunity. Nat. Rev. Immunol. 6, 433\u2013446 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"60208_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/187152612800564455","volume":"12","author":"T Tsubata","year":"2012","unstructured":"Tsubata, T. Role of inhibitory BCR co-receptors in immunity. Infect. Disord. Drug targets 12, 181\u2013190 (2012).","journal-title":"Infect. Disord. Drug targets"},{"key":"60208_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nrrheum.2014.54","volume":"10","author":"J Muller","year":"2014","unstructured":"Muller, J. & Nitschke, L. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease. Nat. Rev. Rheumatol. 10, 422\u2013428 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"60208_CR16","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1002\/art.23812","volume":"58","author":"DH Li","year":"2008","unstructured":"Li, D. H. et al. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis Rheum. 58, 3192\u20133204 (2008).","journal-title":"Arthritis Rheum."},{"key":"60208_CR17","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1084\/jem.20082392","volume":"206","author":"T Kubo","year":"2009","unstructured":"Kubo, T. et al. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J. Exp. Med. 206, 1971\u20131982 (2009).","journal-title":"J. Exp. Med."},{"key":"60208_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","volume":"13","author":"S Bolland","year":"2000","unstructured":"Bolland, S. & Ravetch, J. V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13, 277\u2013285 (2000).","journal-title":"Immunity"},{"key":"60208_CR19","doi-asserted-by":"publisher","first-page":"10156","DOI":"10.1128\/JVI.78.18.10156-10165.2004","volume":"78","author":"E Hemmila","year":"2004","unstructured":"Hemmila, E. et al. Ceacam1a-\/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J. Virol. 78, 10156\u201310165 (2004).","journal-title":"J. Virol."},{"key":"60208_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7217","volume":"6","author":"V Khairnar","year":"2015","unstructured":"Khairnar, V. et al. CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production. Nat. Commun. 6, 6217 (2015).","journal-title":"Nat. Commun."},{"key":"60208_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.semcdb.2007.07.009","volume":"18","author":"N Gupta","year":"2007","unstructured":"Gupta, N. & DeFranco, A. L. Lipid rafts and B cell signaling. Semin. Cell Dev. Biol. 18, 616\u2013626 (2007).","journal-title":"Semin. Cell Dev. Biol."},{"key":"60208_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev.immunol.21.120601.141021","volume":"21","author":"M Dykstra","year":"2003","unstructured":"Dykstra, M., Cherukuri, A., Sohn, H. W., Tzeng, S. J. & Pierce, S. K. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21, 457\u2013481 (2003).","journal-title":"Annu. Rev. Immunol."},{"key":"60208_CR23","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1084\/jem.190.11.1549","volume":"190","author":"PC Cheng","year":"1999","unstructured":"Cheng, P. C., Dykstra, M. L., Mitchell, R. N. & Pierce, S. K. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190, 1549\u20131560 (1999).","journal-title":"J. Exp. Med."},{"key":"60208_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1091\/mbc.02-05-0078","volume":"14","author":"N Gupta","year":"2003","unstructured":"Gupta, N. & DeFranco, A. L. Visualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B-lymphocyte activation. Mol. Biol. Cell 14, 432\u2013444 (2003).","journal-title":"Mol. Biol. Cell"},{"key":"60208_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0952-7915(97)80074-X","volume":"9","author":"AL DeFranco","year":"1997","unstructured":"DeFranco, A. L. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9, 296\u2013308 (1997).","journal-title":"Curr. Opin. Immunol."},{"key":"60208_CR26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nprot.2017.016","volume":"12","author":"J Joung","year":"2017","unstructured":"Joung, J. et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828\u2013863 (2017).","journal-title":"Nat. Protoc."},{"key":"60208_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/10428194.2016.1198958","volume":"58","author":"S Mohanty","year":"2017","unstructured":"Mohanty, S. et al. Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines. Leuk. Lymphoma 58, 676\u2013688 (2017).","journal-title":"Leuk. Lymphoma"},{"key":"60208_CR28","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","volume":"121","author":"MC Vegliante","year":"2013","unstructured":"Vegliante, M. C. et al. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma. Blood 121, 2175\u20132185 (2013).","journal-title":"Blood"},{"key":"60208_CR29","doi-asserted-by":"crossref","unstructured":"Mohanty, A. et al. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Blood 133, 306\u2013318 (2018).","DOI":"10.1182\/blood-2018-05-851667"},{"key":"60208_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/ng1532","volume":"37","author":"K Basso","year":"2005","unstructured":"Basso, K. et al. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37, 382\u2013390 (2005).","journal-title":"Nat. Genet"},{"key":"60208_CR31","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","volume":"49","author":"RM Meyers","year":"2017","unstructured":"Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779\u20131784 (2017).","journal-title":"Nat. Genet."},{"key":"60208_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald, A. et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3, 185\u2013197 (2003).","journal-title":"Cancer Cell"},{"key":"60208_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-106","volume":"8","author":"S Blenk","year":"2008","unstructured":"Blenk, S. et al. Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis. BMC Cancer 8, 106 (2008).","journal-title":"BMC Cancer"},{"key":"60208_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1189\/jlb.1202594","volume":"74","author":"G Greicius","year":"2003","unstructured":"Greicius, G., Severinson, E., Beauchemin, N., Obrink, B. & Singer, B. B. CEACAM1 is a potent regulator of B cell receptor complex-induced activation. J. Leukoc. Biol. 74, 126\u2013134 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"60208_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1189\/jlb.0109037","volume":"86","author":"EO Lobo","year":"2009","unstructured":"Lobo, E. O., Zhang, Z. & Shively, J. E. Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner. J. Leukoc. Biol. 86, 205\u2013218 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"60208_CR36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","volume":"130","author":"EG Rizzatti","year":"2005","unstructured":"Rizzatti, E. G. et al. Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br. J. Haematol. 130, 516\u2013526 (2005).","journal-title":"Br. J. Haematol."},{"key":"60208_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3892\/ijo.2013.1982","volume":"43","author":"Y Kimura","year":"2013","unstructured":"Kimura, Y. et al. The Wnt signaling pathway and mitotic regulators in the initiation and evolution of mantle cell lymphoma: gene expression analysis. Int. J. Oncol. 43, 457\u2013468 (2013).","journal-title":"Int. J. Oncol."},{"key":"60208_CR38","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","volume":"112","author":"P Gelebart","year":"2008","unstructured":"Gelebart, P. et al. Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood 112, 5171\u20135179 (2008).","journal-title":"Blood"},{"key":"60208_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101305","volume":"297","author":"W Hu","year":"2021","unstructured":"Hu, W. et al. Phosphorylation of human CEACAM1-LF by PKA and GSK3beta promotes its interaction with beta-catenin. J. Biol. Chem. 297, 101305 (2021).","journal-title":"J. Biol. Chem."},{"key":"60208_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/bjh.13581","volume":"173","author":"S Iyengar","year":"2016","unstructured":"Iyengar, S. et al. Characteristics of human primary mantle cell lymphoma engraftment in NSG mice. Br. J. Haematol. 173, 165\u2013169 (2016).","journal-title":"Br. J. Haematol."},{"key":"60208_CR41","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/labinvest.2014.61","volume":"94","author":"M Klanova","year":"2014","unstructured":"Klanova, M. et al. Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research. Lab. Invest. 94, 806\u2013817 (2014).","journal-title":"Lab. Invest."},{"key":"60208_CR42","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood-2018-02-832535","volume":"131","author":"PY Kuo","year":"2018","unstructured":"Kuo, P. Y. et al. SOX11 augments BCR signaling to drive MCL-like tumor development. Blood 131, 2247\u20132255 (2018).","journal-title":"Blood"},{"key":"60208_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1182\/blood-2020-143038","volume":"136","author":"DR Edwards","year":"2020","unstructured":"Edwards, D. R. et al. Aberrant cell cycle programming confers rapid lethality in the EuSOX11+ CCND1 MCL mouse model. Blood 136, 6\u20137 (2020).","journal-title":"Blood"},{"key":"60208_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","volume":"128","author":"NS Saba","year":"2016","unstructured":"Saba, N. S. et al. Pathogenic role of B-cell receptor signaling and canonical NF-kappaB activation in mantle cell lymphoma. Blood 128, 82\u201392 (2016).","journal-title":"Blood"},{"key":"60208_CR45","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1073\/pnas.74.5.2021","volume":"74","author":"K Wang","year":"1977","unstructured":"Wang, K. & Singer, S. J. Interaction of filamin with f-actin in solution. Proc. Natl Acad. Sci. USA 74, 2021\u20132025 (1977).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60208_CR46","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1242\/jcs.02660","volume":"118","author":"E Klaile","year":"2005","unstructured":"Klaile, E., Muller, M. M., Kannicht, C., Singer, B. B. & Lucka, L. CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration. J. Cell Sci. 118, 5513\u20135524 (2005).","journal-title":"J. Cell Sci."},{"key":"60208_CR47","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2006.08.026","volume":"25","author":"T Nagaishi","year":"2006","unstructured":"Nagaishi, T. et al. SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 25, 769\u2013781 (2006).","journal-title":"Immunity"},{"key":"60208_CR48","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.4049\/jimmunol.180.9.6085","volume":"180","author":"Z Chen","year":"2008","unstructured":"Chen, Z., Chen, L., Qiao, S. W., Nagaishi, T. & Blumberg, R. S. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70. J. Immunol. 180, 6085\u20136093 (2008).","journal-title":"J. Immunol."},{"key":"60208_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2020.11.126","volume":"535","author":"N Tsugawa","year":"2021","unstructured":"Tsugawa, N. et al. CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. Biochem. Biophys. Res. Commun. 535, 99\u2013105 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"60208_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/imr.12113","volume":"256","author":"W Song","year":"2013","unstructured":"Song, W. et al. Actin-mediated feedback loops in B-cell receptor signaling. Immunol. Rev. 256, 177\u2013189 (2013).","journal-title":"Immunol. Rev."},{"key":"60208_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41770-0","volume":"14","author":"RS Pereira","year":"2023","unstructured":"Pereira, R. S. et al. Distinct and targetable role of calcium-sensing receptor in leukaemia. Nat. Commun. 14, 6242 (2023).","journal-title":"Nat. Commun."},{"key":"60208_CR52","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/ncb1492","volume":"8","author":"R Tavano","year":"2006","unstructured":"Tavano, R. et al. CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse. Nat. Cell Biol. 8, 1270\u20131276 (2006).","journal-title":"Nat. Cell Biol."},{"key":"60208_CR53","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nri2193","volume":"7","author":"A Viola","year":"2007","unstructured":"Viola, A. & Gupta, N. Tether and trap: regulation of membrane-raft dynamics by actin-binding proteins. Nat. Rev. Immunol. 7, 889\u2013896 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"60208_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04832-2","volume":"9","author":"V Khairnar","year":"2018","unstructured":"Khairnar, V. et al. CEACAM1 promotes CD8(+) T cell responses and improves control of a chronic viral infection. Nat. Commun. 9, 2561 (2018).","journal-title":"Nat. Commun."},{"key":"60208_CR55","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nri955","volume":"2","author":"H Niiro","year":"2002","unstructured":"Niiro, H. & Clark, E. A. Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2, 945\u2013956 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"60208_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nm.3435","volume":"20","author":"R Rahal","year":"2014","unstructured":"Rahal, R. et al. Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma. Nat. Med. 20, 87\u201392 (2014).","journal-title":"Nat. Med."},{"key":"60208_CR57","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Bea","year":"2013","unstructured":"Bea, S. et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc. Natl Acad. Sci. USA 110, 18250\u201318255 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60208_CR58","doi-asserted-by":"publisher","first-page":"73558","DOI":"10.18632\/oncotarget.12434","volume":"7","author":"A Mohanty","year":"2016","unstructured":"Mohanty, A. et al. CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma. Oncotarget 7, 73558\u201373572 (2016).","journal-title":"Oncotarget"},{"key":"60208_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"60208_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"60208_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1525-1578(10)60455-2","volume":"5","author":"C Cheadle","year":"2003","unstructured":"Cheadle, C., Vawter, M. P., Freed, W. J. & Becker, K. G. Analysis of microarray data using Z score transformation.  J. Mol. Diagn. 5, 73\u201381 (2003).","journal-title":"J. Mol. Diagn."},{"key":"60208_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60208-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60208-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T20:02:00Z","timestamp":1748462520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60208-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60208"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60208-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5321424\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.P. serves on the Advisory Board at Grail, consults for Regeneron, Genentech\/Roche, and Poseida Therapeutics, and receives research support from Grail, Celgene\/BMS Corporation, Caribou, imCORE, and Poseida Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4967"}}